- Presentations
- 6
- Markets
- 1
Xarelto is a brand of Rivaroxaban marketed by Janssen Pharmaceuticals, with 6 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Rivaroxaban
- Brand owner
- Janssen Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- kit, 155 mg oral suspension, 10 mg tablet, 15 mg tablet, 2.5 mg tablet, 20 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Xarelto kit | Janssen Pharmaceuticals | US FDA | Available on request |
| Xarelto 155 mg oral suspensionOral | Janssen Pharmaceuticals | US FDA | Available on request |
| Xarelto 10 mg tabletOral | Janssen Pharmaceuticals | US FDA | Available on request |
| Xarelto 15 mg tabletOral | Janssen Pharmaceuticals | US FDA | Available on request |
| Xarelto 2.5 mg tabletOral | Janssen Pharmaceuticals | US FDA | Available on request |
| Xarelto 20 mg tabletOral | Janssen Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Xarelto
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.